Cite

HARVARD Citation

    Murphy, A. et al. (2021). Pro: Access to advanced therapies for severe asthma should be restricted to patients with satisfactory adherence to maintenance treatment. Breathe. 17 (2), p. . [Online]. 
  
Back to record